Target
CD52
1 product, 1 indication
Indications
relapsing forms of MS (1 products)
Loading...
1 drug
7 abstracts
Abstract
Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: A case-control study with translational correlates.Org: Departments of Medicine and Oncology, McGill University, Centre de recherche du CHUM, Institut du Cancer de Montréal, Meakins-Christie Laboratories, Department of Medicine, McGill University Health Centre, Division of Cardiology, McGill University,
Abstract
Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL.Org: Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital,
Abstract
Phase 1 results with anti-CD19 allogeneic CAR T ALLO-501/501A in relapsed/refractory large B-cell lymphoma (r/r LBCL).Org: H. Lee Moffitt Cancer Center and Research Institute, University of Miami Sylvester Cancer Center, Ronald Reagan UCLA Medical Center, Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ, Colorado Blood Cancer Institute and Sarah Cannon Research Institute,
Abstract
Effect of disease status prior to T-cell depleted allogeneic stem cell transplantation on relapse-free and overall survival in patients with adverse-risk acute myeloid leukemia (AML).Org: University of Chicago, City of Hope National Medical Center,
Abstract
Investigation of the prognostic significance of CD5, CD117, EZH2, POU2F3, MTAP and BAP1 in thymic carcinoma.Org: Mayo Clinic, Department of Laboratory Medicine and Pathology, University of Washington, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Division of Thoracic Surgery, Brigham and Women's Hospital, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma (AM) in patients with concomitant chronic lymphocytic leukemia (CLL).Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Princess Alexandra Hospital and University of Queensland, Mayo Clinic,
Abstract
Clinical-grade natural killer cells expanded from donor peripheral blood and anti-leukemia effect against myeloid leukemia.Org: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China,
Drug
Alemtuzumab